Log In / Join Now

Magazine Archives: Jan. 31 - Feb. 28, 2011

Resveratrol: Not a Silver Bullet?

Issue: February 28, 2011


GlaxoSmithKline has halted the development of SRT501, an experimental drug based on resveratrol, but that doesn't mean the pharmaceutical firm has stopped developing any medicines based on the compound. Wine Spectator assistant editor Stephanie Cain explains.


For the full article, check out the new issue of Wine Spectator, on newsstands February 1, 2011.

Members-Only Content

PREMIUM SUBSCRIPTION

Created with Sketch.

Join today and get immediate access to this article, and to our entire database of more than 345,000 wine ratings. It only takes moments—but it will help you drink better all year long.

START FREE 30-DAY TRIAL

Already a member?     Sign In


WineRatings+ app: Download now for 340,000+ ratings.